Literature DB >> 2487534

The recent trials for aspirin in the prevention of cardiovascular mortality.

J H Chesebro, L H Opie, V Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2487534     DOI： 10.1007/bf01858107

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  6 in total

1.  Usefulness of aspirin for coronary artery disease.

Authors:  V Fuster; M Cohen; J H Chesebro
Journal:  Am J Cardiol       Date:  1988-03-01       Impact factor: 2.778

2.  Aspirin for the primary prevention of myocardial infarction.

Authors:  A S Relman
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

3.  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

Review 4.  Insights into the pathogenesis of acute ischemic syndromes.

Authors:  V Fuster; L Badimon; M Cohen; J A Ambrose; J J Badimon; J Chesebro
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

5.  Aspirin all round?

Authors:  M Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30

6.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
  6 in total
  1 in total

Review 1.  Treatment of hypertension in the elderly--the end of the story?

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.